Yujie Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yujie Sun has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Chi Xu
Department of Dental Implant Center, Beijing Stomatological Hospital, School of Stomatology Capital Medical University Beijing Beijing P. R. China
2 shared publications- Fu-Jian Xu
State Key Laboratory of Chemical Resource Engineering, Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology, Ministry of Education), Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, China
2 shared publications Wei Geng
Department of Dental Implant Center, Beijing Stomatological Hospital, School of Stomatology Capital Medical University Beijing Beijing P. R. China
2 shared publicationsGuang Yang
Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology), Ministry of Education, Beijing Laboratory of Biomedical Materials Beijing University of Chemical Technology Beijing P. R. China
1 shared publicationMeizhou Sun
School of Chemistry and Chemical Engineering, State Key Laboratory Incubation Base for Green Processing of Chemical Engineering Shihezi University Shihezi P. R. China
1 shared publication- Meizhou Sun
Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology) Ministry of Education Beijing Laboratory of Biomedical Materials Beijing University of Chemical Technology No. 15 Beisanhuan East Road Beijing 100029 China
1 shared publication
Latest Publications
- 20 January 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (35)
Structure‐Function Co‐Assembled Polyphenol‐Diamine Network for Stable, Immunoregulatory, and Contact‐Active Healing of Oral Mucosal Defects
The dynamic and microbially rich environment of the oral cavity poses unique challenges for mucosal repair, where conventional dressings fail to achieve long‐term stability, antimicrobial protection, and immune balance simultaneously. Here, we propose a structure‐function co‐assembled polyphenol‐diamine network that integrates structural robustness and biological functionality into a single interfacial system. Through the covalent co‐assembly of tannic acid and polyhexamethylene guanidine (PHMG), the network forms a release‐free antibacterial interface in which guanidinium groups remain covalently anchored yet maintain contact‐active bactericidal capability, achieving a long‐term of killing efficacy (over 96%) against S. aureus and E. coli without side effects. Concurrently, the polymerized polyphenol framework provides strong tissue adhesion via covalent anchoring and hydrogen bonding, while exerting antioxidant and immunoregulatory effects that guide macrophage polarization toward a pro‐healing M2 phenotype and promote angiogenesis through the PI3K/Akt/HO‐1 and PI3K/Akt/HIF‐1α/VEGF signaling axes. These co‐assembled biointerfaces achieve long‐term antibacterial stability, immune microenvironment reconstruction, and accelerated tissue repair under dynamic physiological conditions. The presented polyphenol‐diamine co‐assembly strategy provides a versatile and translatable strategy for engineering multifunctional, release‐free, and immunomodulatory biointerfaces across diverse tissue repair scenarios.
- 20 January 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (35)
Structure‐Function Co‐Assembled Polyphenol‐Diamine Network for Stable, Immunoregulatory, and Contact‐Active Healing of Oral Mucosal Defects
The dynamic and microbially rich environment of the oral cavity poses unique challenges for mucosal repair, where conventional dressings fail to achieve long‐term stability, antimicrobial protection, and immune balance simultaneously. Here, we propose a structure‐function co‐assembled polyphenol‐diamine network that integrates structural robustness and biological functionality into a single interfacial system. Through the covalent co‐assembly of tannic acid and polyhexamethylene guanidine (PHMG), the network forms a release‐free antibacterial interface in which guanidinium groups remain covalently anchored yet maintain contact‐active bactericidal capability, achieving a long‐term of killing efficacy (over 96%) against S. aureus and E. coli without side effects. Concurrently, the polymerized polyphenol framework provides strong tissue adhesion via covalent anchoring and hydrogen bonding, while exerting antioxidant and immunoregulatory effects that guide macrophage polarization toward a pro‐healing M2 phenotype and promote angiogenesis through the PI3K/Akt/HO‐1 and PI3K/Akt/HIF‐1α/VEGF signaling axes. These co‐assembled biointerfaces achieve long‐term antibacterial stability, immune microenvironment reconstruction, and accelerated tissue repair under dynamic physiological conditions. The presented polyphenol‐diamine co‐assembly strategy provides a versatile and translatable strategy for engineering multifunctional, release‐free, and immunomodulatory biointerfaces across diverse tissue repair scenarios.
- Top Cited Papers
- 1 July 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (37) , e2506113
Surface‐Engineered Orthopedic Implant to Break the Antimicrobial‐Osteogenic Paradox at Biointerfaces in the “Race for the Surface”
Implant‐associated infections and compromised osseointegration pose a dual threat to bone implants due to the biological conflict between microbial invasion and host cell colonization. However, conventional contact‐killing antimicrobial coatings may negatively affect the viability of mammalian cells, limiting their further application. Here, a surface modification strategy is proposed to help mammalian cells to win the “race for the surface” on the material‐tissue interfaces. Through polyphenol‐amine‐mediated covalent modification, quaternary ammonium groups (bactericidal agents) and phosphate groups (promoting bone‐regeneration factors) are spatially organized on titanium (Ti) surfaces to regulate the surface chemical characteristics of dental implants. The surface‐engineered implants (Ti‐AQs) exhibited balanced antibacterial and biocompatible properties. The optimized Ti‐AQ‐2 coating eradicated >99% of Staphylococcus aureus ( S. aureus) and Escherichia coli ( E. coli) via destruction of disrupted bacterial membranes through metabolic interference, and simultaneously promoted adhesion, proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells through Ca 2+ ‐mediated signaling pathways. Moreover, Ti‐AQs can drive immunomodulation biased macrophages toward pro‐repair M2 polarization. In vivo evaluations in an implant‐associated infection modal confirmed that Ti‐AQ‐2 inhibited infection at the early stage and enhanced bone‐implant integration at the late stage. This work presents a facile strategy to regulate the surface performances for developing of antibacterial implants with high biocompatibility and bioactivity.
- 1 July 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (37) , e2506113
Top Cited PapersSurface‐Engineered Orthopedic Implant to Break the Antimicrobial‐Osteogenic Paradox at Biointerfaces in the “Race for the Surface”
Implant‐associated infections and compromised osseointegration pose a dual threat to bone implants due to the biological conflict between microbial invasion and host cell colonization. However, conventional contact‐killing antimicrobial coatings may negatively affect the viability of mammalian cells, limiting their further application. Here, a surface modification strategy is proposed to help mammalian cells to win the “race for the surface” on the material‐tissue interfaces. Through polyphenol‐amine‐mediated covalent modification, quaternary ammonium groups (bactericidal agents) and phosphate groups (promoting bone‐regeneration factors) are spatially organized on titanium (Ti) surfaces to regulate the surface chemical characteristics of dental implants. The surface‐engineered implants (Ti‐AQs) exhibited balanced antibacterial and biocompatible properties. The optimized Ti‐AQ‐2 coating eradicated >99% of Staphylococcus aureus ( S. aureus) and Escherichia coli ( E. coli) via destruction of disrupted bacterial membranes through metabolic interference, and simultaneously promoted adhesion, proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells through Ca 2+ ‐mediated signaling pathways. Moreover, Ti‐AQs can drive immunomodulation biased macrophages toward pro‐repair M2 polarization. In vivo evaluations in an implant‐associated infection modal confirmed that Ti‐AQ‐2 inhibited infection at the early stage and enhanced bone‐implant integration at the late stage. This work presents a facile strategy to regulate the surface performances for developing of antibacterial implants with high biocompatibility and bioactivity.